홈 › 두경부 편평세포암 › 펜실베이니아 › Philadelphia
PA Philadelphia의 두경부 편평세포암 임상 시험
두경부 편평세포암 관련 연구 26개가 Philadelphia 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
피험자 모집 중3상
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13마일 거리
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
피험자 모집 중1상
- Exelixis Clinical Site #98, Philadelphia
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
피험자 모집 중3상
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
피험자 모집 중2상
- Thomas Jefferson University Hospital, Philadelphia
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
피험자 모집 중3상
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
피험자 모집 중1상
- University of Pennsylvania, Philadelphia
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
피험자 모집 중2상
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- University of Pennsylvania, Philadelphia
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
피험자 모집 중2상
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
피험자 모집 중2상
- Research Site, Philadelphia
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
피험자 모집 중관찰 연구
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
피험자 모집 중2상
- Asplundh Cancer Pavilion, Willow Grove · 13마일 거리
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
피험자 모집 중1상
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
피험자 모집 중2/3상
- Thomas Jefferson University Hospital, Philadelphia
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
피험자 모집 중3상
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23마일 거리
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25마일 거리
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- University of Pennsylvania, Philadelphia
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
피험자 모집 중1상
- Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
피험자 모집 중3상
- GSK Investigational Site, Philadelphia
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
피험자 모집 중1상
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
피험자 모집 중1상
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
피험자 모집 중3상
- Fox Chase Cancer Center, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- University of Pennsylvania, Philadelphia
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
피험자 모집 중
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
피험자 모집 중3상
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
다른 도시의 두경부 편평세포암 시험
- Houston, TX연구 47개
- Los Angeles, CA연구 42개
- Boston, MA연구 40개
- New York City, NY연구 39개
- Nashville, TN연구 39개
- St. Louis, MO연구 28개
- Arlington, VA연구 26개
- Chicago, IL연구 26개
- Atlanta, GA연구 24개
- San Antonio, TX연구 22개
- Pittsburgh, PA연구 22개
- New Haven, CT연구 22개
Philadelphia의 다른 연구
- 암 (전체)연구 59개
- 유방암연구 56개
- 비소세포폐암연구 51개
- 전이성 암연구 46개
- 전립선암연구 44개
- 대장직장암연구 44개
- 난소암연구 44개
- 폐암연구 36개
- 급성 골수성 백혈병연구 34개
- 심부전연구 31개
- 자궁내막암연구 28개
- 우울증연구 26개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.